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INCIDENCE OF DENTAL IMPLANT FAILURE IN ACADEMIC SETTING - A CLINICAL
RETROSPECTIVE STUDY PART ONE: PATIENT LEVEL
Abstract
Aim: The aim of this retrospective study was to determine the implant failure rate and associated factors
in the academic setting by using electronic health records (Axium) and hard copies of patients who
received dental implants at in Penn Dental Medicine (PDM) and at Penn Dental Faculty Ppractices (PDFP)
ofat the University of Pennsylvania from 06/01/2016 to 08/31/201920
20. In addition, evaluation of
electronic health records and hard copies were reviewed for patients who had implants removed due to
bone loss or lack of osseointegration atin PDM and Faculty practicesPDFP of the University of
Pennsylvania from 06/01/2016 to 02/29/2020. Secondary objective was to investigate the cocontributing factors for implant failure at the patient level.
Method and Material: Electronic health records and hard copies of patients who had implants placed and
removed due to bone loss or lack of osseointegration atin PDM and Faculty practicesPDFP of the
University of Pennsylvania from 06/01/2016 to 02/29/2020 were analyzed.
Results: Data was evaluated at patient count and implant count for this retrospective study. 1609 patients
received implants. 883 patients had implant placement at PDM and 726 patients had implant placement
at PDFP. Of the total patients, 3180 implants were placed during the study period. 2162 implants were
placed at PDM and 1018 implants were placed at PDFP. The total patient failure rate was 4.97% and the
failure rate was of 6.0% and 3.7% for PDM and PDFP, respectively. The total implant failure rate was 3.49%
and the implant failure rate was 3.7% and 3% for PDM and PDFP, respectively.
Based on the chi-square test results, patients with bisphosphonate IV+PO (12%, P-value=0.004) were
significantly overrepresented in the failure group. In contrast, patients with no bisphosphonate use
(4.60%, P-value=0.004) were significantly underrepresented in the failure group.
No overrepresentation (or underrepresentation) of patients with different gender, different age group,
diabetes mellitus, history of periodontal disease, current smoking status, penicillin allergy, and recall were
noted amongst failures.
Based on the chi-square test, implants for bisphosphonate IV variable (11.5%, P-value=0.025) were
significantly overrepresented in the failure group. In contrast, implants for no bisphosphonate use (3.20%,
P-value<0.001) were significantly underrepresented in the failure group. No overrepresentation (or
underrepresentation) of implants for different gender, different age group, diabetes mellitus, history of
periodontal disease, current smoking status, penicillin allergy, and recall was noted amongst failures.
Based on the multivariate conditional logistic regression, estimated odds of implant failure in participants
with multiple implants were about three times than the participants with single implant (Adj OR=2.99, Pvalue=0.002); estimated odds of implant failure for bisphosphonate use of IV and PO was about four
times that of the participants with no bisphosphonate use (Adj. OR=4.09, P-value=0.003). Diabetes and
history of failed implants did not show any significant association with implant failure (with Pvalues>0.05).
Conclusion: This study concluded that bisphosphonate use and patients with multiple implants were
shown to have a significant contribution to implant failure. There was no difference in the failure rate of
patients with different gender, different age group, diabetes mellitus, history of periodontal disease,
current smoking status, penicillin allergy, and recallamongst failures. It is important to note that due to
limitations and the retrospective nature of this study, only the co-contributing factors were evaluated and
not the etiology of the implant failure. To further investigate the etiology, randomized clinical trial should

be conducted.
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Abstract

Aim: The aim of this retrospective study was to determine the implant failure rate and associated
factors in the academic setting by using electronic health records (Axium) and hard copies of
patients who received dental implants at Penn Dental Medicine (PDM) and at Penn Dental Faculty
Practice (PDFP) of the University of Pennsylvania from 06/01/2016 to 08/31/2019. In addition,
evaluation of electronic health records and hard copies were reviewed for patients who had
implants removed due to bone loss or lack of osseointegration at PDM and PDFP of the University
of Pennsylvania from 06/01/2016 to 02/29/2020. Secondary objective was to investigate the cocontributing factors for implant failure at the patient level.

Method and Material: Electronic health records and hard copies of patients who had implants
placed and removed due to bone loss or lack of osseointegration at PDM and PDFP of the
University of Pennsylvania from 06/01/2016 to 02/29/2020 were analyzed.

Results: Data was evaluated at patient count and implant count for this retrospective study. 1609
patients received implants. 883 patients had implant placement at PDM and 726 patients had
implant placement at PDFP. Of the total patients, 3180 implants were placed during the study
period. 2162 implants were placed at PDM and 1018 implants were placed at PDFP. The total
patient failure rate was 4.97% and the failure rate was of 6.0% and 3.7% for PDM and PDFP,

respectively. The total implant failure rate was 3.49% and the implant failure rate was 3.7% and
3% for PDM and PDFP, respectively.
Based on the chi-square test results, patients with bisphosphonate IV+PO (12%, P-value=0.004)
were significantly overrepresented in the failure group. In contrast, patients with no
bisphosphonate use (4.60%, P-value=0.004) were significantly underrepresented in the failure
group.
No overrepresentation (or underrepresentation) of patients with different gender, different age
group, diabetes mellitus, history of periodontal disease, current smoking status, penicillin allergy,
and recall were noted amongst failures.
Based on the chi-square test, implants for bisphosphonate IV variable (11.5%, P-value=0.025)
were significantly overrepresented in the failure group. In contrast, implants for no bisphosphonate
use (3.20%, P-value<0.001) were significantly underrepresented in the failure group. No
overrepresentation (or underrepresentation) of implants for different gender, different age group,
diabetes mellitus, history of periodontal disease, current smoking status, penicillin allergy, and
recall was noted amongst failures.
Based on the multivariate conditional logistic regression, estimated odds of implant failure in
participants with multiple implants were about three times than the participants with single implant
(Adj OR=2.99, P-value=0.002); estimated odds of implant failure for bisphosphonate use of IV
and PO was about four times that of the participants with no bisphosphonate use (Adj. OR=4.09,
P-value=0.003). Diabetes and history of failed implants did not show any significant association
with implant failure (with P-values>0.05).

Conclusion: This study concluded that bisphosphonate use and patients with multiple implants
were shown to have a significant contribution to implant failure. There was no difference in the
failure rate of patients with different gender, different age group, diabetes mellitus, history of
periodontal disease, current smoking status, penicillin allergy, and recall amongst failures. It is
important to note that due to limitations and the retrospective nature of this study, only the cocontributing factors were evaluated and not the etiology of the implant failure. To further
investigate the etiology, randomized clinical trial should be conducted.

Introduction

The discovery of osseointegration has had a huge impact on implant dentistry for the last 50 years.
This began with Branemark defining osseointegration as a “direct structural and functional contact
between ordered, living bone and the surface of a load-carrying implant”.

1

Furthermore, he

experimented with more than 50 different types of implants and introduced the threaded design of
dental implant to the dental community in the early 1980s and still, this design is widely used to
this day.

According to literature, dental implants have been expanded over the last decade as a valid
replacement of missing teeth. Implant survival rates has been reported in the literature as 91.6%.
1-7

However, not all implants are without failure. Implant failure can be classified as early or late
failure. Early failure is defined when osseointergration has not been established and late failure is
when the established osseointegration is breaking down. Biological, microbiological, and
biomechanical factors can contribute to implant loss; however, the mechanism of early implant
failure is still unclear. 8 However, according to 2017 Workshop, late implant failure is mainly
associated with peri-implantitis, which is characterized by progressive bone loss of supporting
bone. 31

According to Moraschini (20015), osseointegrated implants present high survival rates with
minimal marginal bone resorption in the long term. 9 However, there is strong evidence that there
is an increased risk of developing peri-implantitis in patients with history of periodontitis, poor
oral hygiene, and no regular maintenance. 10,11 Ong et al. (2008) concluded in a literature review
that patients treated for periodontitis may experience more implant loss and complications around
implants than non-periodontitis patients.

12

Moreover, Karoussis et al. (2007) reported that a

history of chronic periodontitis was associated with significantly greater long-term probing depth,
peri-implant marginal bone loss, and peri-implantitis.

13

Furthermore, Baelum and Ellegaard

(2007) concluded 5-year survival rate of implants placed in patients with a history of periodontitis
was similar to that of patients without periodontitis.

14

Heitz-Mayfield (2008) found substantial

evidence that poor oral hygiene, history of periodontitis, and cigarettes smoking were associated
with peri-implantitis, but more studies were needed to confirm these as true factors.15 According
to the most recent studies, there is no conclusive evidence that smoking, diabetes, lack of
keratinized mucosa, excess cement, genetic factors, systemic conditions, occlusal overload, bone
compression, overheating, micro-motion, and biocorosion are risk factors for peri-implantitis.
However, a meta-analysis reported that smokers had a greater risk of implant failure (implantrelated odds ratio [OR] of 2.25) when compared to nonsmokers.16 Biological factors may be
associated with implant failures in smokers such as vasoconstrictive effect of nicotine, impaired
and delayed wound healing, and cytotoxic effect on fibroblasts and other regenerative cells.17, 18
In diabetic patients, a glycemic control is an essential variable in providing the optimal periodontal
and implant treatment. Many studies showed that poor glycemic control has negative impact on

the outcome of the therapy, but more studies are needed to provide a definitive conclusion. 19 In
systematic literature review by Javed (2009), osseointegration can be achieved in patients with
well controlled diabetes.20
In addition to systemic disease, there have been studies that show that medications may have
negative impact on implant survival. According to American Association of Oral and Maxillofacial
Surgeons, bisphosphonate can cause Medication Related Osteonecrosis of the Jaw (MRONJ) and
is usually prescribed for patients with osteoporosis, osteopenia, and cancer.21 In a survey study of
more than 13,000 Kaiser permanent members who were exposed to long term oral bisphosphonates
due to osteoporosis, the prevalence of MRONJ was reported to be 0.1% (10 cases per 10,000).
This number was increased to 0.21% (21 cases per 10,000) in patients receiving oral
bisphosphonate longer than 4 years.22 Another report by Malden and Lopes (2012) from 11 cases
of MRONJ reported in 90,000 patients in southeast Scotland, they reported an incidence of 0.004%
(0.4 cases per 10,000 patient-years of exposure to Alendronate).23 Furthermore, with regards to
MRONJ risk in patients with osteoporosis exposed to IV bisphosphonate or RANKL inhibitors, a
study evaluated patients exposed to yearly Zoledronate for 3 years with the risk for MRONJ of
0.017% (1.7 cases per 10,000 patients).

24

Based on current data, the risk of MRONJ in patients

with osteoporosis who are taking oral or IV bisphosphonates still exists, yet remains very low. 21
With all the limitation regarding the use of oral and IV bisphosphonate, some studies show
bisphosphonates do not reduce the dental implant success rate.

25

In addition, patients with

penicillin allergy have shown a higher risk of implant failure when compared to non-allergic
patients with a risk ratio of 3.84 (95% CI). Patients prescribed clindamycin due to penicillin allergy
had four times earlier implant failure; however, other variables such as location, brand, and

surgeon’s experience could have influenced the results.

26

Another limited evidence in literature

that needs to be investigated is the effect of age and gender on short and long implant survival rate.

Another factor that may influence implant survival is the implant site, position, and bone quality.
Implant treatments require careful planning to achieve prosthetically driven implant surgery.
Furthermore, implant sites may be treated differently due to horizontal and vertical changes after
extraction.27 According to Cochran and Becker et al. (1999), maxillary implants showed lower
survival rate than mandibular implants.28, 29

In addition to anatomical limitations, experience may play a role in early implant failure.
According to Lambert (1997), implants placed by inexperienced resident surgeons failed twice
compared to the ones placed by more experienced resident surgeons with the failure rate being
5.9% for the inexperienced residents and 2.4% for the more experienced residents. The main
difference was noted in the first nine cases but after these nine cases, the failure rate decreased
significantly.30

Furthermore, literature shows that the early failure of implants with bone graft and healing
abutments at the same time (1.1%) was significantly higher than that of the implants with bone
graft and healing abutments separately (0.5%, P=0.039).32 Due to limitations and lack of evidence,
this retrospective study can provide a better understanding of the effect of co-existing factors in
implant survival rates.

The aim of this retrospective study was to determine the implant failure rate and associated factors
in the academic setting by using electronic health records (AxiUm) and hard copies of patients
who received dental implants at Penn Dental Medicine (PDM) and at Penn Dental Faculty Practice
(PDFP) of the University of Pennsylvania from 06/01/2016 to 08/31/2019. Electronic health
records and hard copies of patients who had implants removed due to bone loss or lack of
osseointegration at PDM and PDFP of the University of Pennsylvania from 06/01/2016 to
02/29/2020 were searched and analyzed.

As the primary objective of this study, the failed implants were identified and categorized.
As the secondary objective, data was categorized as patient level and implant level. Patient level
included the patient’s past medical history (diabetes, history of bisphosphonates, smoking, and
penicillin allergy), patient’s age, gender, history of periodontal disease, and implant follow up;
The implant level included implant site, width, length, diameter, manufacturer, surface
characteristics, immediate implant, implants placed in grafted or non-grafted sites, and the
prosthesis type (fixed/removable). The tertiary objective of this study was to assess whether
experience played a role in implant survival rate.

Materials and Methods

This study obtained approval from the institutional review Board of the University of
Pennsylvania. The search involved electronic health records from AxiUm data base software and
hard copies of qualifying patients from PDM and PDFP. Study was conducted by two examiners
(R.H and O.M). Electronic health records and hard copies were searched and analyzed for patients
who received dental implants at PDM and PDFP from 06/01/2016 to 08/31/2019 as well as patients
who had implants removed due to bone loss or lack of osteointegration in both PDM and PDFP
from 06/01/2016 to 02/29/2020. Implant placement (ADA Code D6010) and implant removal
(ADA Code D6100) were checked for the same site in each of these patients. Implant placement
and failure were confirmed by existence of implant checklist and hard copies, ADA code, and
clinical note. Dates of implant placement and removal were documented.

Additional data was extracted from the records for both patient level and implant level. Data was
categorized as implant count and patient count for both PDM and PDFP for patient level and
implant level with timeline A- from 06/01/2016 to 08/31/2019 and timeline B- from 06/01/2016
to 02/29/2020.

With regard to “Implant Count” the following categories were identified for patient level
analysis:

1- Implant placement and implant removal
1-1-Total number of implants placed (D6010) during time line A.
1-2-Total number of implants placed during time line A and removed (D6100) during time line B.
The implants in this category should have had codes D6100 in addition to code D6010 during the
dates mentioned above.
1-3- The number of implants placed (D6010) during time line A in each of the following
categories: female, male, age (18-30 y/o), age (31-50 y/o), age (51-70 y/o), age (70<), diabetes,
smoking, bisphosphonate (IV, oral), and penicillin allergy.
1-4- The number of implants removed (D6100) during time line B in each of the following
categories: female, male, age (18-30 y/o), age (31-50 y/o), age (51-70 y/o), age (70<), diabetes,
smoking, bisphosphonate (IV, oral), and penicillin allergy.
2- Periodontal Disease and follow ups/Periodontal Maintenance
2-1 Total number of implants placed (D6010) during time line A, in patients with history of
periodontal disease (codes D499T2, D499T3, D499T4, D4999.1) within no specific time line
(since the beginning of becoming a patient at PDM).
2-1-1 Total number of implants in category 2-1, in the above patients who have been
coming for their periodontal maintenance (any of the following codes D110, D4910,
D4910.2, D4910.3, D4910.4) during time line B. Furthermore, the number of times these
codes (D110, D4910, D4910.2, D4910.3, D4910.4) were completed was considered to
determine whether the patients were coming for regular maintenance and follow ups or not.
2-2 Total number of implants placed (D6010) during time line A and the implant removed (D6100)

during time line B, in patients who also have a history of periodontal disease (codes D499T2,
D499T3, D499T4, D4999.1) within no specific time line (since the beginning of becoming a
patient at PDM).
2-2-2 Total number of implants in category 2-2, in the above patients who also have been
coming for their periodontal maintenance (any of the following codes D110, D4910,
D4910.2, D4910.3, D4910.4) during time line B. Furthermore, the number of times these
codes (D110, D4910, D4910.2, D4910.3, D4910.4) were completed was considered to
determine whether the patients were coming for regular maintenance and follow ups or not.
3- Recall
3-1 Total number of implants placed (D6010) during time line A and the history of recalls (codes
D110, D4910, D4910.2, D4910.3, D4910.4) during time line B. As well as the number of the times
these codes (D110, D4910, D4910.2, D4910.3, D4910.4) were completed to determine whether
the patients were coming for regular maintenance and follow ups or not.
3-2 Total number of implants received (D6010) during time line A and the implant removed
(D6100) during timeline B, and the history of recalls (codes D110, D4910, D4910.2, D4910.3,
D4910.4) during time line B. Furthermore, the number of the times these codes (D110, D4910,
D4910.2, D4910.3, D4910.4) were completed was considered to determine whether the patients
were coming for regular maintenance and follow ups or not.
With regard to “patient Count” the following categories were identified for patient level analysis:

1- Implant placement and implant removal

1-1-Total number of patients who had implants placed (D6010) during time line A.
1-2-Total number of patients who had implants placed during time line A and removed (D6100)
during time line B. The patients in this category should have had codes D6100 in addition to code
D6010 during the dates mentioned above.
1-3- The number of patients who received implants (D6010) during time line A in each of the
following categories: female, male, age (18-30 y/o), age (31-50 y/o), age (51-70 y/o), age (70<),
diabetes, smoking, bisphosphonate (IV, oral), and penicillin allergy.
1-4- The number of patients who had implants removed (D6100) during time line B in each of the
following categories: female, male, age (18-30 y/o), age (31-50 y/o), age (51-70 y/o), age (70<),
diabetes, smoking, bisphosphonate (IV, oral), and penicillin allergy.
2- Periodontal Disease and follow ups/Periodontal Maintenance
2-1 Total number of patients who received implants (D6010) during time line A, who also have a
history of periodontal disease (codes D499T2, D499T3, D499T4, D4999.1) within no specific time
line (since the beginning of becoming a patient at PDM).
2-1-1 Total number patients in category 2-1, who also have been coming for their
periodontal maintenance (any of the following codes D110, D4910, D4910.2, D4910.3,
D4910.4) during time line B. Furthermore, the number of times these codes (D110, D4910,
D4910.2, D4910.3, D4910.4) were completed was considered to determine whether the
patients were coming for regular maintenance and follow ups or not.
2-2 Total number of patients who received implant (D6010) during time line A and had that
implant removed (D6100) during time line B, who also have a history of periodontal disease (codes
D499T2, D499T3, D499T4, D4999.1) within no specific time line (since the beginning of

becoming a patient at PDM).
2-2-2 Total number patients in category 2-2, who also have been coming for their
periodontal maintenance (any of the following codes D110, D4910, D4910.2, D4910.3,
D4910.4) during time line B. Furthermore, the number of times these codes (D110, D4910,
D4910.2, D4910.3, D4910.4) were completed was considered to determine if they were
coming for regular maintenance and follow ups or not.
3- Recall
3-1 Total number of patients who received implant (D6010) during time line A and their history
of recalls (codes D110, D4910, D4910.2, D4910.3, D4910.4) during time line B. As well as the
number of the times these codes (D110, D4910, D4910.2, D4910.3, D4910.4) were completed (to
determine if they were coming for regular maintenance and follow ups or not).
3-2 Total number of patients who received implant (D6010) during time line A and had the implant
removed (D6100) during timeline B, and their history of recalls (codes D110, D4910, D4910.2,
D4910.3, D4910.4) during time line B. Furthermore, the number of the times these codes (D110,
D4910, D4910.2, D4910.3, D4910.4) were completed was considered to determine whether the
patients were coming for regular maintenance and follow ups or not.

Exclusion criteria included implants placed outside of Penn Dental and removed at Penn Dental,
implants placed or removed at Penn Dental outside of the study timeframe, cases with vague or
ambiguous documentation, and patients younger than 18 years old.

Statistical Analysis

Data were analyzed using SPSS v.24 (IBM Corp. Released 2016. IBM SPSS Statistics for
Windows, Version 24.0. Armonk, NY: IBM Corp.), and Stata v.15 (Stata Corp. 2017. Stata
Statistical Software: Release 15. College Station, TX: Stata Corp LLC.).

A chi-square test was applied to compare the implant failure distribution between the different
categories of potential risk factors (a P-value≤0.05 was considered as significant). The null
hypothesis (𝐻0 ) was that the implant failure rate is independent from the potential risk factors; i.e.,
the different level of a particular risk factor does not change the implant failure ratio. The Chisquare test was applied in both patient-level and implant-level.

This was a matched-case-control study with a 1:3 ratio (1 case matched to 3 controls) consisted of
99 patients with implant failure(s) and 297 matched controls. Cases were matched based on age,
gender, site, and trainee-group. The descriptive statistics were first reported to explain the data,
including, number and percentage. The overall incidence of failure was calculated in both patientlevel and implant-level.

We applied a univariate conditional logistic regression as a feature selection method to select the
most relevant factors affecting the implant failure - to be considered in the final multivariate

logistic regression model. Variables with a univariate P-value<0.2 were considered as important
variables and got selected as the covariate for the final multivariate conditional logistic regression.
The multivariate conditional logistic regression was applied to find the potential risk factors
affecting the implant failure and report the odds ratios, called adjusted odds ratio (Adj. ORs).
Covariates with a multivariate P-value≤0.05 were considered as significant potential risk factors.

Twenty-year-old female patient with implant failure #Q was excluded from matching due to not
having a controlled group.

Results

The data and results were analyzed in patient count and implant count:

Patient Count
During the study period a total of 1609 patients received implants, out of which 883 patients
received implants at PDM and 726 patients received implants at PDFP. The total rate of patients
with failed implants was 4.9%. This is the sum of patients with failed implant of 6% and 3.7% for
PDM and PDFP, respectively.

Implant Count
A total of 3180 implants were placed during the study period. 2162 implants were placed at PDM
and 1018 implants were placed at PDFP. The total failed implant rate was 3.4%. This is the sum
of implant failure rate of 3.7% and 3% for PDM and PDFP, respectively.

Based on the chi-square test results in Table 1C, patients with bisphosphonate IV+PO (12%, Pvalue=0.004) were significantly overrepresented in the failure group. In contrast, patients with no
bisphosphonate use (4.60%, P-value=0.004) were significantly underrepresented in the failure
group.

No overrepresentation (or underrepresentation) of patients with different gender, different age
group, diabetes mellitus, history of periodontal disease, current smoking status, penicillin allergy,
and recall was noted amongst failures.

Based on the chi-square test results in Table 2C, all of PO+IV bisphosphonate use was statistically
significant (9.80%, P-value <0.001). Implants for bisphosphonate IV variable (11.5%, Pvalue=0.025) were significantly overrepresented in the failure group. In contrast, implants for no
bisphosphonate use (3.20%, P-value<0.001) were significantly underrepresented in the failure
group. No overrepresentation (or underrepresentation) of implants for different gender, different
age group, diabetes mellitus, history of periodontal disease, current smoking status, penicillin
allergy, and recall was noted amongst failures.

Conditional Logistic Regression

Based on the frequency distributions of the variables (Table 3A), frequencies of the current
smokers (n=4), subjects with penicillin allergy (n=2), IV bisphosphonate use (n=5), and diabetes
(n=6) were very low, which may result in unreliable odds ratios (ORs) in the conditional logistic
regression.

Matching variables were not considered in the conditional logistic regression model (age, gender,
trainee group). Univariate conditional logistic regression was applied as a variable-selection step.
Variables with a univariate P-value≤0.2 were selected to be entered into the final multivariate
logistics regression model.

Based on the univariate conditional logistic regression results in Table 3B, total implant (OR=3.15,
P-value=0.001), history of periodontal disease (OR=0.68, P-value=0.208), bisphosphonate use
(OR=3.88, P-value=0.003), and diabetes (OR=3.0, P-value=0.178) were selected (with Pvalue≤0.2) as the final variables to be entered in the multivariate conditional logistic regression.
Based on the multivariate conditional logistic regression results in Table 3B, estimated odds of
implant failure in participants with multiple implants were about three times than participants with
single implant (Adj OR=2.99, P-value=0.002); estimated odds of implant failure for
bisphosphonate use of IV and PO were about four times than participants with no bisphosphonate
use (Adj. OR=4.09, P-value=0.003). Diabetes and history of failed implants did not show any
significant association with implant failure (with P-values>0.05).

The conditional logistic regression was initially calculated with “Bisphosphonate use” with three
categories (results presented in table 4). However, the odds ratio for the “IV” category became
OR=121.17 due to the sparse data in this category (n=5, refer to Table 3A). Therefore, the model
was re-calculated with “Bisphosphonate use” with two categories.

Tables

Table 1C. Patients with failed implants according to gender, age and past medical histories
(diabetes, bisphosphonates, periodontal disease, and smoking status)
Patients
% of
Expected
Who
Patients
Patients
Patients
Receive
Pwith
Variable
with
with Failures
d
value
Failures
Failures
Implant
(Under 𝐻0 )
(Under 𝐻0 )
s
Entire sample
1609
80
4.97%
Gender
Male
691
28
4.10%
34.9
0.110
Female
892
52
5.80%
45.1
0.108
Unknown
1
0
Age (in years)
18-30
63
1
1.60%
3.1
0.207
31-50
379
12
3.20%
18.8
0.064
51-70
816
48
5.90%
40.6
0.088
70<
351
19
5.40%
17.5
0.667
Diabetes (Type 1 and Type
18
2
11.10%
0.9
0.228
2)
Diabetes Type 1
2
0
0%
0.1
1.000
Diabetes Type 2
16
2
12.50%
0.8
0.164
No diabetes
1591
78
4.90%
79.1
0.228
Bisphosphonates (IV + PO)
75
9
12%
3.7
0.004*
Bisphosphonate IV
14
2
14.30%
7.0
0.107
Bisphosphonate PO
61
7
11.50%
3.0
0.017*
No Bisphosphonates
1534
71
4.60%
76.3
0.004*
Hx of Periodontal Disease
362
16
4.40%
18.0
0.583
No periodontal
1247
64
5.10%
62.0
0.583
disease
Current Smoker
18
1
5.60%
0.9
0.909
Non-smoker
1591
79
5%
79.1
0.909
Penicillin Allergy
16
1
6.20%
0.8
0.813
No penicillin allergy
1593
79
5%
79.2
0.813

Patients with Recall
Non-recall patient

1236
373

55
25

4.40%
6.70%

61.5
18.5

0.079
0.079

* Significant with P-value<0.05. P-values are based on a chi-square test.

Table 2C. Implant’s demographics
Implan
ts
placed
Variable
in
patient
s
Entire sample
3180
Gender
Male
1391
Female
1788
Unknown
1
Age (in years)
18-30
110
31-50
595
51-70
1787
70<
663
Diabetes (Type 1 and
70
Type 2)
Diabetes Type 1
2
Diabetes Type 2
68
No Diabetes
3110
Bisphosphonates (IV +
133
PO)
Bisphosphonate
26
IV
Bisphosphonate
107
PO
No
3047
Bisphosphonates
Hx of Periodontal
730
Disease
No periodontal
2450
disease
Current Smoker
33
Non-smoker
3147
Penicillin Allergy
24

Failed
Implants

% of
Failures
(Under
𝑯𝟎 )

Expected
Implants
with Failures
(Under 𝑯𝟎 )

Pvalue

111

3.49%

40
71
0

2.90%
4.00%

48.6
62.4

0.094
0.096

1
15
68
27

0.90%
2.50%
3.80%
4.10%

3.8
20.8
62.4
23.1

0.133
0.153
0.273
0.359

3

4.30%

2.4

0.714

0
3
108

0.00%
4.40%
3.50%

0.1
2.4
3.5

13

9.80%

4.6

1.000
0.676
0.714
<0.00
1*

3

11.50%

0.9

0.025*

10

9.30%

4.6

0.001*

98

3.20%

106.4

<0.00
1*

19

2.60%

25.5

0.136

92

3.80%

85.5

0.136

0
111
2

0.00%
3.50%
8.30%

1.2
109.8
0.8

0.272
0.272
0.194

No penicillin
allergy
Patients with Recall
Non-recall patient

3156

109

3.50%

110.2

0.194

2145
1035

74
37

3.40%
3.60%

74.9
36.1

0.857
0.857

* Significant with P-value<0.05. P-values are based on a chi-square test.

Table 3A. Frequency of different variables
Variable
level
Outcome
Fail
Success
Sex
Female
Male
Site
Max Post
Max Ant
Mand Post
Mand Ant
Arch
Mandibular
Maxillary
Location
Posterior
Anterior
Trainee group
PDM
PDFP
Total Implant
Single
Multiple
Smoking
No
Yes
Penicillin Allergy
No
Yes
History of
No
Periodontal Diseases
Yes
Recall
No
Yes
Bisphosphonate use No
IV
PO
Diabetes
No
Type II

Number
99
297
252
144
124
84
128
60
188
208
252
144
280
116
117
279
392
4
394
2
307

%
25.0
75.0
63.3
36.4
31.3
21.2
32.3
15.2
47.5
52.5
63.3
36.4
70.7
29.3
29.5
70.5
99.0
1.0
99.5
0.5
77.5

89
138
258
370
5
21
390
6

22.5
34.8
65.2
93.4
1.3
5.3
98.5
1.5

Table 3B. Results of the univariate and multivariate conditional logistic regression. Variables
with a univariate P-value≤0.2 are selected to be entered into the final multivariate logistics
regression.
Univariate Analysis
Multivariate Analysis
Variable

Total Implant

Category

Single
Multiple

Smoking

History of Periodontal
Disease

Bisphosphonate use

No

Adj

95%

CI

value

OR**

CI

0.001

2.99

1.586.26

P-value

0.4221.29

3.0

0.1947.96

1.486.02

0.002

0.271

-

ref

0.437

-

ref

0.68

0.371.24

0.208

0.70

ref
1.03

No
IV & PO

Diabetes

3.0

No
Yes

P-

ref

No

Yes
Recall

3.15

No
Yes

95%

ref

No
Yes

Penicillin Allergy

OR*

0.601.78

0.371.32

0.267

0.891

-

ref
3.88

1.589.54
ref

0.003

4.09

1.6110.35

0.003

Type II

3.0

0.6014.86

0.178

* Odds Ratio
** Adjusted Odds Ratio

Table 4
Variable
Category OR*
95% CI
P-value
Bisphosphonate use No
ref
IV
13.37 1.47-121.17 0.021
PO
2.87
1.06-7.78
0.037

2.24

0.4211.80

0.341

Discussion

Implant failure can be characterized by clinical and radiographic findings such as implant mobility,
suppuration around the implant, implant bone loss, lack of osseointegration, progressive bone
resorption, peri-implantitis, and patient complaint.33 Implant failures have been associated with
multiple factors. These factors include poor bone quality or lack of bone volume, smoking habits,
infection, host response, implant instability, and unfavorable implant loading. 34

Implant failures can be divided into early or late failures. Early failure occurs prior to delivery of
restorative abutment. Late failure happens after implant loading. This recognition is critical to
know for practitioners as the etiology of them are different.

35

In early failure there is inadequate

bone to implant contact due to impaired bone healing and fibrous scar tissue formation instead of
bone apposition. This leads to epithelial down growth or marsupialization that can lead to implant
loss.

36, 37, 38

There have been patient related and implant related factors identified for this early

implant failure such as smoking habit, metabolic disorders, implant features, quality and quantity
of bone, surgery related factors, and the use of grafted bone. 39, 40 The late failures are associated
with overload induced peri-implantitis and plaque induced peri-implantitis.41 In a systematic
review by Berglundh (2002), incidence of early implant loss was reported to be between 0.76%
and 7.47% and late implant loss between 2.1% and 11.3% in studies with 5 to 10 years follow up.
42

This study investigated implant failure co-contributing factors at the patient level. It was noted that
the majority of the implant failures happened prior to final restorative abutment insertion, which
indicates these failures to be categorized as early implant failures. Failure rate in patient level was
found to be equal to 4.97% (95% CI: 3.90, 6.03) while failure rate in implant level was 3.49%
(95% CI: 2.85, 4.13). In this study no overrepresentation (or underrepresentation) of patients with
different gender, different age group, diabetes mellitus, periodontal disease, current smoking
status, penicillin allergy, and recall was noted amongst failures.

Age and Gender
According to our findings, patient demographics such as gender and age were not over or under
represented thus not related to the early implant failure. These results are in agreement with
Steenberghe et al. (2002) that also found no direct correlation of age and gender with early implant
failure.43

History of Periodontal Disease, Recall, Smoking
Heitz-Mayfield (2008) found substantial evidence that poor oral hygiene, history of periodontitis,
and cigarettes smoking were associated with peri-implantitis and limited evidence that poorly
controlled diabetes and alcohol consumption is associated with peri-implantitis, but more studies
are needed to confirm these as true factors.15 Baelum and Ellegaard (2004) found no difference in
a 5-year implant survival rate study in patients with history of periodontitis compared to patients
without it.14 Similarly, Klokkevold and Han (2007) determined that there is no statistically
significant difference for survival rate of implants placed in patients with a history of treated

periodontitis compared to patients with no history of periodontitis (95% and 97.1% respectively).44
This is in accordance to the results of the present study. On the contrary, in a systematic review,
Ong et al. (2008) concluded that patients treated for periodontitis may experience more implant
failure compared to non-periodontitis patients.12 However, evaluating the correlation of
periodontitis or history of recall and implant failure may be better evaluated with late implant
failure as the peri-implantitis takes longer to occur.

Tran et al. (2016) conducted a long-term retrospective study regarding survival of dental implants
placed in grafted and non-grafted sites and found that smoking and lack of professional
maintenance were significantly related to increased implant loss.45 Similarly, a meta-analysis by
Manzano et al. (2016) and a systematic review by Strietzel et al. (2007) concluded that smoking
increases the risk of early implant failure. 46, 47 However, in the present study smoking did not play
a role as a contributing factor for implant failure. This may have been due to small number of
patients who had implant failure with smoking habit, thereby reducing the power of the statistical
analysis. Based on the frequency distributions of the variables (Table 3A), frequencies of the
current smokers (n=4) were very low, which may result in unreliable odds ratios (ORs) in the
conditional logistic regression. Another restrictive factor may have been that the smoking habit
was self-reported and may have been biased. In addition, Sverzut et al (2008) stated that tobacco
alone cannot be considered a risk factor for early implant loss. On the contrary, Alsaadi et al (2007)
reported that smoking may have a dose dependent effect on osseointegration and is associated with
early implant failure. 47, 48

Diabetes Mellitus

Another important factor to consider when implant placement is the presence of diabetes mellitus
and the glycemic status of the patient. Moy et al. (2005) noted that implant failure was significantly
higher among patients who were 60 years or older, smoked, and had a history of diabetes.49 Oates
et al. (2009) reported that alterations with the implant stability due to impaired implant integration
in people with type 2 diabetes mellitus with HbA1c greater or equal to 8.1%, is in direct relation
to their hyperglycemic condition.50 Javed et al. (2009) reported that implant osteointegration can
be reached in patients with well controlled diabetes.20 This is in accordance with the results of this
study that showed no statistically significant difference between implant failure rate of patients
with controlled diabetes compared to patients without diabetes. In the present study, the diabetes
mellitus status was self-reported by patients and implant surgery was done only if diabetes had
been reported to be controlled. The self-reported control of diabetes may have caused bias.

Bisphosphonate
A meta-analysis by Ata-Ali et al. (2014) reported that receiving bisphosphonates does not reduce
the success rate of dental implants, yet such patients are not without complications. Furthermore,
risk evaluation has to be done on an individual basis and there was not enough evidence and studies
included in this report.51 Similarly, in a study by Fugazzottoo et al. (2007), 61 patients with history
of oral bisphosphonate therapy for a mean period of 3.3 years were followed up 12-24 months
after implant placement. The history of oral bisphosphonate use was not found to be a contributing
factor for developmental of osteonecrosis following implant placement either in extractions
sockets with immediate implant placement or in intact ridges. However, they recommended a
larger controlled studies and retrospective reports.52 Furthermore, Jeffcoat (2006) conducted two
controlled clinical studies and found that oral bisphosphonate use was not associated with

occurrence of osteonecrosis of the jaw.

53

On the contrary, Jacobsen et al. (20013) noted that

implants that are placed in the posterior regions have higher risk of development of osteonecrosis
of the jaws. They mentioned that the implant placement as well as the implant by itself can be a
continuous risk factor. 54 Another study by Tam et al. (2012) reported that unusual jaw necrosis
following dental implant placement can be related to oral and/or intravenous bisphosphonate use.
They stated that key factors for successful healing in these situations are collagen graft, resection
of necrotic tissue, and primary closure.55 According to the present study, bisphosphonate use is
associated with implant failure rate (Adj. OR=4.09, P-value=0.003).

Penicillin Allergy
According to a cross sectional study by Salomo-Coll et al. (2018), patients with allergy to
penicillin, who received clindamycin prophylactically and post surgically following implant
surgery, exhibited 3.84 times more implant failure compared to non-allergic patients who received
amoxicillin. However, the authors mentioned that these results could have been influenced by other
factors such as implant brand, surgical skill, and location of the implant.26 The present study did
not show any statistically significant correlation between implant failure rate in patients with
penicillin allergy or non-allergic patients. However, this study evaluated 394 subjects with no
allergy to penicillin and 2 subjects with allergy. This results in an unreliable OR in conditional
logistic regression. Therefore, a bigger sample size is needed in this category to be able to reliably
compare them with each other.

Multiple vs. Single Implant Placement and Provider Expertise

Cluster phenomenon, which is defined as multiple implant failure in the same patient, supports the
evidence that certain characteristics in each individual can influence the early implant failure.
These characteristics can include age, bone quality, taking antidepressants, and bruxism.56, 57

According to an analysis of a large number of clinical follow up studies with Branemark implants,
the failure rate was noted to be 7.7% in a 5 year follow up, excluding grafted sites. They noted
early failure rate of 3.8% and 2% for partially edentulous and fully edentulous, respectively and
total failure rate was 3.4% for partially edentulous and 7.6% for fully edentulous patients. This can
be due to a better patient selection in terms of age, health, and anatomical conditions, as well as
more favorable load distribution. Overall, higher failure rates were observed for overdenture.36, 58

The results of this study showed that patients who received more than one implant either at the
same time or different time periods had statistically significant more implant failure rate compared
to patients who received only one implant (P-value=0.002). This can be due to anatomical
limitations, patient’s overall poor oral hygiene, host response, impaired healing due to undiagnosed
or uncontrolled disease, and the technique sensitivity of the surgery. In other words, placing
multiple implants requires more planning and superior surgical skills. Another factor for the
increase in failure rate may be due to atrophic ridge, which may require additional procedures, and
size and characteristics of the implant. These factors will be discussed more in details in the second
part of this study.

Espositio et al. (1998b) stated experienced dentist may have a better patient and site selection,
better technique, minimal surgical trauma and bacterial contamination, thus have less failures. 58

Traumatic surgery can cause soft tissue encapsulation of the implants. 59 Furthermore, overheating
has been deemed to be the most probable cause of early implant failures. 60

As part of the study design for collecting data with matched-case-control technique with a 1:3
ratio, trainees covariate were matched; therefore, they could not be used as covariate in logistic
regression analysis and there could not be a true comparison of these groups with regard to the
implant failure rate.

Limitations of the study

The findings of this study were subject to some limitations. One of the limitations was that patients’
self-reporting of medical condition and tobacco use may have been subject to their recall bias.
Also, the survival rate of implants that were placed but patient did not come back for follow up is
unknown. Moreover, due to Penn Dental policy, there was access to limited number of the charts
to review for more detailed information. Based on the frequency distributions of the variables
(Table 3A), frequencies of the failed implants in current smokers (n=4), subjects with penicillin
allergy (n=2), bisphosphonate use IV (n=5), and diabetes (n=6) were very low, which may have
resulted in unreliable odds ratios (ORs) in the conditional logistic regression. Thus, it is
recommended to have bigger sample size in each of these categories in the future studies to be able
to have a logistical comparison.

Conclusion

Implant therapy can be a reliable treatment option to replace missing teeth. This retrospective study
investigated early implant failure. The primary objective of this retrospective study was to assess
implant failure rate in academic setting. The total failure rate for PDM and PDFP was within the
reported failure range of the literature. Co-contributing factors were stratified in patient level and
implant level. In this study, the focus was the patient level.

This study concluded that bisphosphonate use and patients with multiple implants were shown to
have a significant contribution to implant failure. There was no difference in the failure rate of
patients with different gender, different age group, diabetes mellitus, periodontal disease, current
smoking status, penicillin allergy, and recall amongst failures.

It is important to note that due to limitations and the retrospective nature of this study, only the cocontributing factors were evaluated and not the etiology of the implant failure. To investigate the
etiology, randomized clinical trial should be conducted. Yet, the clinicians should be aware of the
increased risk of early implant failure with bisphosphonate use and in cases with multiple implant
therapy.
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